Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
$4.44+0.26 (+6.22%)
Close on Nov 13, 2026Market cap $110.06MP/E –Yield –
Lexaria Bioscience operating margin
Operating margin is operating income as a percentage of revenue.
Lexaria Bioscience's operating margin for the twelve months ending May 31, 2026 was -3973.2%. For fiscal 2025 it was -1683.0%, against -1239.2% the year before. The highest annual figure on record is -786.8% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | -1683.0% | −443.9 |
| FY2024 | Aug 31, 2024 | -1239.2% | +1649.3 |
| FY2023 | Aug 31, 2023 | -2888.5% | −296.8 |
| FY2022 | Aug 31, 2022 | -2591.7% | −1804.8 |
| FY2021 | Aug 31, 2021 | -786.8% | +2350.0 |
| FY2016 | Aug 31, 2016 | -3136.8% | +10353.0 |
| FY2015 | Aug 31, 2015 | -13489.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | -7259.5% | −5796.6 |
| Q4 FY2025CQ3 2025 | Aug 31, 2025 | -1545.2% | +1077.5 |
| Q3 FY2025CQ2 2025 | May 31, 2025 | -2155.4% | −80.5 |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | -1581.0% | −1120.3 |
| Q1 FY2025CQ4 2024 | Nov 30, 2024 | -1463.0% | −709.9 |
| Q4 FY2024CQ3 2024 | Aug 31, 2024 | -2622.7% | +1001.5 |
| Q3 FY2024CQ2 2024 | May 31, 2024 | -2074.9% | +1014.7 |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | -460.7% | +6149.2 |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | -753.0% | +981.7 |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | -3624.2% | −2950.7 |
| Q3 FY2023CQ2 2023 | May 31, 2023 | -3089.6% | −664.4 |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | -6609.9% | −2410.6 |
| Q1 FY2023CQ4 2022 | Nov 30, 2022 | -1734.7% | −476.9 |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | -673.5% | +128.1 |
| Q3 FY2022CQ2 2022 | May 31, 2022 | -2425.2% | −76.1 |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | -4199.3% | −509.6 |
| Q3 FY2021CQ2 2021 | May 31, 2021 | -1257.8% | +3084.3 |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -801.6% | +3014.7 |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -2349.1% | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -3689.7% | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -4342.0% | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -3816.2% | – |
See a number that looks wrong?